Rigel Pharmaceuticals Inc (RIGL)

3.36
0.57 15.00
NASDAQ : Health Care
Prev Close 3.93
Open 3.76
Day Low/High 3.31 / 3.83
52 Wk Low/High 1.88 / 4.06
Volume 12.76M
Avg Volume 690.90K
Exchange NASDAQ
Shares Outstanding 94.59M
Market Cap 249.72M
EPS -0.60
P/E Ratio 4.40
Div & Yield N.A. (N.A)

Latest News

Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug

Rigel Pharma Claims Late-Stage Study Win for Blood Platelet Drug

The 18% response rate for fostamatinib in the Rigel phase III study was on the lower end of investor expectations.

Rigel's Fostamatinib Meets Primary Endpoint In Phase 3 Study In Chronic ITP

Rigel's Fostamatinib Meets Primary Endpoint In Phase 3 Study In Chronic ITP

Conference call and webcast today at 8:00 AM Eastern Time

Rigel Pharmaceuticals (RIGL) Weak On High Volume Today

Rigel Pharmaceuticals (RIGL) Weak On High Volume Today

Trade-Ideas LLC identified Rigel Pharmaceuticals (RIGL) as a weak on high relative volume candidate

Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer

Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer

Elliott Grossbard, M.D. Retires; Continues Advising on Fostamatinib in the ITP Program

Short Interest In Rigel Pharmaceuticals Makes 14.2% Move

Short Interest In Rigel Pharmaceuticals Makes 14.2% Move

The most recent short interest data has been released by the NASDAQ for the 06/15/2015 settlement date, which shows a 355,726 share increase in total short interest for Rigel Pharmaceuticals Inc , to 2,855,027, an increase of 14.23% since 05/29/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today

Rigel Pharmaceuticals (RIGL) Strong On High Relative Volume Today

Trade-Ideas LLC identified Rigel Pharmaceuticals (RIGL) as a strong on high relative volume candidate

Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized Using Options

Commit To Purchase Rigel Pharmaceuticals At $2.50, Earn 11.3% Annualized Using Options

Investors considering a purchase of Rigel Pharmaceuticals Inc shares, but tentative about paying the going market price of $3.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2.50 strike, which has a bid at the time of this writing of 15 cents.

Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies

Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies

The pharma giant is making an upfront payment of $800 million and committing to up to $450 million more in milestone payments.

Rigel And Bristol-Myers Squibb Announce Research And Development Collaboration For TGF Beta Receptor Kinase Inhibitors For Use In Immuno-Oncology Related Indications

Rigel And Bristol-Myers Squibb Announce Research And Development Collaboration For TGF Beta Receptor Kinase Inhibitors For Use In Immuno-Oncology Related Indications

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) and Bristol-Myers Squibb Company (NYSE:BMY) today announced that they have entered into a collaboration agreement for the discovery, development and commercialization of...